@phdthesis{Tabares2011, author = {Tabares, Paula}, title = {Antimicrobial, anti-protease and immunomodulatory activities of secondary metabolites from Caribbean sponges and their associated bacteria}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-67000}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2011}, abstract = {Marine sponges and their associated bacteria have been proven to be a rich source of novel secondary metabolites with therapeutic usefulness in infection and autoimmunity. This Ph.D. project aimed to isolate bioactive secondary metabolites from the marine sponges Amphimedon compressa, Aiolochroia crassa and Theonella swinhoei as well as from bacteria associated with different Caribbean sponges, specifically actinomycetes and sphingomonads. In this study, amphitoxin was isolated from the crude methanol extract of the sponge A. compressa and it was found to have antibacterial and anti-parasitic activities. Amphitoxin showed protease inhibitory activity when tested against the mammalian protease cathepsin B and the parasitic proteases rhodesain and falcipain-2. Furthermore, miraziridine A was identified in the dichloromethane extract of the sponge T. swinhoei collected offshore Israel in the Red Sea. Miraziridine A, a natural peptide isolated previously from the marine sponge Theonella aff. mirabilis, is a potent cathepsin B inhibitor with an IC50 value of 1.4 g/mL (2.1 M). Secondary metabolites from sponge-derived bacteria were also isolated and identified. A total of 79 strains belonging to 20 genera of the order Actinomycetales and seven strains belonging to two genera of the order Sphingomonadales were cultivated from 18 different Caribbean sponges and identified by 16S rRNA gene sequencing. Seven of these strains are likely to represent novel species. Crude extracts from selected strains were found to exhibit protease inhibition against cathepsins B and L, rhodesain, and falcipain-2 as well as immunomodulatory activities such as induction of cytokine release by human peripheral blood mononuclear cells. The isolates Sphingobium sp. CO105 and Lapillicoccus sp. BA53 were selected for cultivation, extraction and purification of bioactive metabolites based on initial bioactive screening results. The isoalloxazine isolumichrome was isolated from the strain Sphingobium sp. CO105 which inhibited the protease rhodesain with an IC50 of 0.2 M. The strain Lapillicoccus sp. BA53 was found to produce p-aminosalicylic acid methyl ester, which showed activity against the proteases cathepsins B and L, falcipain-2 and rhodesain. These results highlight the significance of marine sponge-associated bacteria to produce bioactive secondary metabolites with therapeutic potential in the treatment of infectious diseases and disorders of the immune system.}, subject = {Schw{\"a}mme}, language = {en} } @phdthesis{Jadulco2002, author = {Jadulco, Raquel C.}, title = {Isolation and structure elucidation of bioactive secondary metabolites from marine sponges and sponge-derived fungi}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-3565}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2002}, abstract = {Low-molecular mass natural products from bacteria, fungi, plants and marine organisms exhibit unique structural diversity which are of interest for the identification of new lead structures for medicinals and agrochemicals. In the search for bioactive compounds from marine sponges and sponge-associated fungi, this research work resulted to the isolation of twenty-six compounds, eight of which are new metabolites. The sponges were collected from the Indo-pacific regions, particularly those from Indonesian and Philippine waters, as well as those from the Mediterranean Sea near the island of Elba in Italy. A combination of the chemically- and biologically-driven approach for drug discovery was employed, wherein extracts were screened for antibacterial, antifungal and cytotoxic activities. In addition to the bioassay-guided approach to purify the compounds responsible for the activity of the extract, TLC, UV and MS were also used to isolate the chemically most interesting substances. Hence, purified compounds which are not responsible for the initial bioscreening activity may have a chance to be evaluated for other bioactivities. Enumerated below are the compounds which have been isolated and structurally elucidated and whose bioactivities have been further characterized. 1. The extract of the fungus Cladosporium herbarum associated with the sponge Callyspongia aerizusa afforded seven structurally related polyketides, including two new twelve-membered macrolides: pandangolide 3 and 4, and a new acetyl congener of the previously isolated 5-hydroxymethyl-2-furoic acid. The two furoic acid analogues isolated were found to be responsible for the antimicrobial activity of the extract. The isolation of the known phytotoxin Cladospolide B from Cladosporium herbarum, which was originally known from Cladosporium cladosporioides and C. tenuissimum, indicates the possibility that Cladospolide B may be a chemotaxonomic marker of particular Cladosporium species. 2. The extract of the fungus Curvularia lunata associated with the Indonesian sponge Niphates olemda yielded three compounds, namely the new antimicrobially-active anthraquinone lunatin, the known bisanthraquinone cytoskyrin A, and the known plant hormone abscisic acid. The co-occurrence of the two structurally-related anthraquinones suggests that the monomeric lunatin may be a precursor in the biosynthesis of the bisanthraquinone cytoskyrin A. 3. The fungus Penicillium spp. associated with the Mediterranean sponge Axinella verrucosa yielded six compounds, namely the known antifungal griseofulvin and its less active dechloro analogue; the known toxin oxaline; and the known cytotoxic metabolite communesin B and its two new congeners communesin C and D. The new communesins were less active than communesin B in the brine-shrimp lethality test. 4. An unidentified fungus which was also isolated from the same Mediterranean sponge Axinella verrucosa as Penicillium spp. yielded the known compound monocerin which has been reported to possess phytotoxic and insecticidal activities. 5. The fungus Aspergillus flavus associated with the Philippine sponge Hyrtios aff. reticulatus yielded the known toxin a-cyclopiazonic acid. 6. The Indonesian sponge Agelas nakamurai yielded four bromopyrrole alkaloids namely the new compound 4-bromo-pyrrole-2-carboxylic acid, and the known compounds: 4-bromo-pyrrole-2-carboxamide, mukanadin B and mukanadin C. All of the four compounds except mukanadin B were found to be antimicrobially-active. Bromopyrrole alkaloids are well-known metabolites of the genus Agelas and are proven to play an important role in the chemical defense of the sponge against predation from fishes. 7. The Indonesian sponge Jaspis splendens yielded three known substances which are known for their antiproliferative activities, namely the depsipeptides jaspamide (jasplakinolide), and its derivatives jaspamide B and jaspamide C.}, subject = {Meeresschw{\"a}mme}, language = {en} } @phdthesis{Cheng2017, author = {Cheng, Cheng}, title = {Metabolomics and dereplication-based isolation of novel bioactive natural products from marine sponge-associated actinomycetes}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-136587}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2017}, abstract = {Marine sponge-associated actinomycetes are considered as promising source for the discovery of novel biologically active compounds. Metabolomics coupled multivariate analysis can efficiently reduce the chemical redundancy of re-isolating known compounds at the very early stage of natural product discovery. This Ph.D. project aimed to isolate biologically active secondary metabolites from actinomycetes associated with different Mediterranean sponges with the assistance of metabolomics tools to implement a rapid dereplication and chemically distinct candidate targeting for further up-scaling compounds isolation. This study first focused on the recovery of actinomycetes from marine sponges by various cultivation efforts. Twelve different media and two separate pre-treatments of each bacterial extract were designed and applied to facilitate actinomycete diversity and richness. A total of 64 actinomycetes were isolated from 12 different marine sponge species. The isolates were affiliated to 23 genera representing 8 different suborders based on nearly full-length 16S rRNA gene sequencing. Four putatively novel species belonging to the genera Geodermatophilus, Microlunatus, Rhodococcus, and Actinomycetospora were identified based on a sequence similarity <98.5\% to validly described 16S rRNA gene sequences. 20\% of the isolated actinomycetes was shown to exhibit diverse biological properties, including antioxidant, anti-Bacillus sp., anti-Aspergillus sp., and antitrypanosomal activities. The metabolomics approaches combined with the bioassay results identified two candidate strains Streptomyces sp. SBT348 and Streptomyces sp. SBT345 for further up-scaling cultivation and compounds isolation. Four compounds were isolated from Streptomyces sp. SBT348. Three of these compounds including the new cyclic dipeptide petrocidin A were previously highlighted in the metabolomics analyses, corroborating the feasibility of metabolomics approaches in novel compounds discovery. These four compounds were also tested against two pathogen microorganisms since the same activities were shown in their crude extract in the preliminary bioassay screening, however none of them displayed the expected activities, which may ascribe to the insufficient amount obtained. Streptomyces sp. SBT345 yielded 5 secondary metabolites, three of which were identified as new natural products, namely strepthonium A, ageloline A and strepoxazine A. Strepthonium A inhibited the production of Shiga toxin produced by enterohemorrhagic Escherichia coli at a concentration of 80 μM, without interfering with the bacterial growth. Ageloline A exhibited antioxidant activity and inhibited the inclusion of Chlamydia trachomatis with an IC50 value of 9.54 ± 0.36 μM. Strepoxazine A displayed antiproliferative property towards human promyelocytic HL-60 cells with an IC50 value of 16 μg/ml. 11 These results highlighted marine sponges as a rich source for novel actinomycetes and further exhibited the significance of marine sponge-associated actinomycetes as promising producers of novel biologically active compounds. The chemometrics coupled metabolomics approach also demonstrated its feasibility and efficacy in natural product discovery.}, subject = {Actinomyces}, language = {en} } @phdthesis{PimentelElardo2008, author = {Pimentel Elardo, Sheila Marie}, title = {Novel anti-infective secondary metabolites and biosynthetic gene clusters from actinomycetes associated with marine sponges}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-40463}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2008}, abstract = {Marine sponges (Porifera) harbor diverse microbial communities within their mesohyl, among them representatives of the phylum Actinobacteria, commonly known as actinomycetes. Actinomycetes are prolific producers of pharmacologically important compounds and are responsible for producing the majority of antibiotics. The main aim of this Ph.D. study was to investigate the metabolic potential of the sponge-associated actinomycetes to produce novel anti-infective agents. The first aim was to cultivate actinomycetes derived from different marine sponges. 16S rDNA sequencing revealed that the strains belonged to diverse actinomycete genera such as Gordonia, Isoptericola, Micromonospora, Nocardiopsis, Saccharopolyspora and Streptomyces. Phylogenetic analyses and polyphasic characterization further revealed that two of these strains represent new species, namely Saccharopolyspora cebuensis strain SPE 10-1T (Pimentel-Elardo et al. 2008a) and Streptomyces axinellae strain Pol001T (Pimentel-Elardo et al. 2008b). Furthermore, secondary metabolite production of the actinomycete strains was investigated. The metabolites were isolated using a bioassay-guided purification scheme followed by structure elucidation using spectroscopic methods and subjected to an elaborate anti-infective screening panel. Several interesting compounds were isolated namely, the novel polyketides cebulactam A1 and A2 (Pimentel-Elardo et al. 2008c), a family of tetromycin compounds including novel derivatives, cyclodepsipeptide valinomycin, indolocarbazole staurosporine, diketopiperazine cycloisoleucylprolyl and butenolide. These compounds exhibited significant anti-parasitic as well as protease inhibitory activities. The third aim of this Ph.D. study was to identify biosynthetic gene clusters encoding for nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) present in the actinomycete strains. Genomic library construction and sequencing revealed insights into the metabolic potential and biosynthetic pathways of selected strains. An interesting NRPS system detected in Streptomyces sp. strain Aer003 was found to be widely distributed in several sponge species, in an ascidian and in seawater and is postulated to encode for a large peptide molecule. Sequencing of the PKS gene cluster of Saccharopolyspora cebuensis strain SPE 10-1T allowed the prediction of the cebulactam biosynthetic pathway which utilizes 3-amino-5-hydroxybenzoic acid as the starter unit followed by successive condensation steps involving methylmalonyl extender units and auxiliary domains responsible for the polyketide assembly. In conclusion, this Ph.D. study has shown that diverse actinomycete genera are associated with marine sponges. The strains, two of them novel species, produced diverse chemical structures with interesting anti-infective properties. Lastly, the presence of biosynthetic gene clusters identified in this study substantiates the biosynthetic potential of actinomycetes to produce exploitable natural products and hopefully provides a sustainable supply of anti-infective compounds.}, subject = {Meeresschw{\"a}mme}, language = {en} }